KALVISTA PHARMACEUTICALS, INC.

Transcripts KalVista Pharmaceuticals, Inc.

Equities

KALV

US4834971032

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
11.92 ^USD	-1.24%		-1.32%	-2.69%

Apr. 22	Kalvista Pharmaceuticals, Inc. Appoints William C. Fairey to the Board of Directors	CI
Apr. 15	Certain Common Stock of KalVista Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 15-APR-2024.	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : KalVista Pharmaceuticals, Inc. - Special Call	Feb. 13
Transcript : KalVista Pharmaceuticals, Inc. Presents at H.C. Wainwright 1st Annual Hereditary Angioedema Conference, Jul-20-2022	22-07-20
Transcript : KalVista Pharmaceuticals, Inc. Presents at Needham 21st Annual Healthcare Conference, Apr-13-2022 03:00 PM	22-04-13
Transcript : KalVista Pharmaceuticals, Inc. Presents at 11th SVB Leerink Annual Global Healthcare Conference 2022, Feb-16-2022 09:20 AM	22-02-16
Transcript : KalVista Pharmaceuticals, Inc. Presents at Cantor Global Healthcare 2021 Conference, Sep-27-2021 08:40 AM	21-09-27
Transcript : KalVista Pharmaceuticals, Inc. - Special Call	21-02-09
Transcript : KalVista Pharmaceuticals, Inc. Presents at Jefferies 2019 London Healthcare Conference, Nov-21-2019 08:00 AM	19-11-21
Transcript : KalVista Pharmaceuticals, Inc. Presents at Stifel 2019 Healthcare Conference, Nov-19-2019 08:00 AM	19-11-19

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW